Teva Pharmaceutical Industries Ltd.

5 Basel Street, PO Box 3190,
Petach Tikva, 49131
+972 3 926 7267

Teva Pharmaceutical Industries Ltd. is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (1.6/yr) # 15 2 5 1 - - 23
vol $29.8B $344M $46.0B $500M $76.7B
Sell (1.2/yr) # 2 - 1 1 3 1 8
vol $49M $586M $2.5B $3.1B

Top M&A Advisors

Financial Deals
Sign-up to View
Sign-up to View
Sign-up to View
Legal Deals
Sign-up to View
Sign-up to View
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Allergan Generics
$40.5B (2015-07-27)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Teva Pharmaceutical Industries Ltd. - PARAGARD
$1.1B (2017-09-11)

According to our data here at Mergr, Teva Pharmaceutical Industries has acquired 23 companies, including 8 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 8 assets.

Teva Pharmaceutical Industries’ largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It’s largest disclosed sale occurred in 2017, when it sold Teva Pharmaceutical Industries - PARAGARD to CooperSurgical for $1.1B. Teva Pharmaceutical Industries has acquired in 7 different US states, and 8 countries. The Company’s most targeted sectors include life science (87%) and distribution (5%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 410 life science companies that have made at least 1 acquisition, 16 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Teva Pharmaceutical Industries’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.